JABRX
Price
$47.27
Change
-$0.06 (-0.13%)
Updated
Jun 18 closing price
Net Assets
26.09B
RLBCX
Price
$35.44
Change
-$0.02 (-0.06%)
Updated
Jun 18 closing price
Net Assets
244.53B
Interact to see
Advertisement

JABRX vs RLBCX

Header iconJABRX vs RLBCX Comparison
Open Charts JABRX vs RLBCXBanner chart's image
Janus Henderson Balanced S
Price$47.27
Change-$0.06 (-0.13%)
VolumeN/A
Net Assets26.09B
American Funds American Balanced R3
Price$35.44
Change-$0.02 (-0.06%)
VolumeN/A
Net Assets244.53B
JABRX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JABRX vs. RLBCX commentary
Jun 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JABRX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 245B vs. JABRX (26.1B). RLBCX (1.63) and JABRX (1.56) have matching dividends . JABRX was incepted earlier than RLBCX: JABRX (16 years) vs RLBCX (23 years). JABRX (1.07) is less costly to investors than RLBCX (0.89). JABRX is a more actively managed with annual turnover of: 76.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than JABRX: RLBCX (250) vs JABRX (2500). RLBCX annual gain was more profitable for investors over the last year : 4.09 vs. JABRX (2.78). JABRX return over 5 years is better than : 38.14 vs. RLBCX (35.80).
JABRXRLBCXJABRX / RLBCX
Total Expense Ratio1.070.89120%
Annual Report Gross Expense Ratio1.070.89120%
Fund Existence16 years23 years-
Gain YTD4.1524.38395%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets26.1B245B11%
Annual Yield % from dividends1.561.6395%
Returns for 1 year2.784.0968%
Returns for 3 years34.0133.16103%
Returns for 5 years38.1435.80107%
Returns for 10 years73.7454.69135%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGMT7.040.16
+2.33%
Sagimet Biosciences
NWG14.170.14
+1.00%
NatWest Group plc
CYTK32.730.19
+0.58%
Cytokinetics
BBDC9.070.03
+0.33%
Barings BDC
PSHG1.92-0.12
-5.88%
Performance Shipping